1) targeting therapy
导向治疗
1.
Advances in clinical targeting therapy of cancer;
肿瘤导向治疗的最新临床研究进展
2.
Objective: To observe the targeting therapy of the hdsFv-RC-RNase recombinant single chain immunotoxin on the xenograft of the human hepatocellular carcinoma in nude mice and to explore its clinical potentiality.
目的观察抗肝癌重组单链免疫毒素hdsFv-RC-RNase对荷人肝癌裸鼠移植瘤的导向治疗作用,并探讨其临床应用价值。
3.
The same object of all kinds of targeting therapy is to kill tumor cells specifically and to reduce the side effect on normal cells.
特异性地杀伤肿瘤细胞并降低对正常细胞的毒副作用是各种导向治疗方法的共同目标。
2) target therapy
导向治疗
1.
Because immunotoxin of CTX has the ability to kill target cells efficiently and specifically,it shows to be an expected pathway in target therapy for cancer.
由于细胞毒素类免疫毒素能高效、特异地杀伤靶细胞,因此选择眼镜蛇毒细胞毒素用于肿瘤导向治疗将是一条很有希望的途径。
2.
Monoclonal antibody(McAb) has been used as main carrier system in traditional target therapy of osteosarcoma, but it s molecule weight is high and power of pierce through tissue and cell membrane is lower and can induce human anti-mouse antibody responses (KA.
导向治疗具有此优点，既增强药物的特异性，提高疗效，同时又减少对正常组织和细胞的损伤，其关键在于具备高效导向性的载体系统。
3) Targeted radiopharmaceutic therapy
放射导向治疗
4) gene-directed drug therapy
基因导向性治疗
1.
The development of pharmacogenetics and pharmacogenomics promotes the observation of ethnic differences of drug response and clarification of its mechanism, which makes the mode of drug treatment shift from diagnosis-directed drug therapy to gene-directed drug therapy on the basis of individual genetic structure.
遗传药理学和药物基因组学的发展,促进了药物反应种族差异的发现及其机制的阐明,使药物治疗模式开始由过去的诊断导向治疗向根据个体的遗传机构实行基因导向性治疗的新模式转换。
5) molecular targeting therapy
分子导向治疗
补充资料：导向治疗
分子式：
CAS号：
性质：用有一定特异性的抗体为载体，将药物或其他杀伤肿瘤细胞的物质选择性地运送到肿瘤部位，特异地杀伤肿瘤细胞，以提高治疗效果的一种治疗方法。目前应用的细胞物质有三类，放射性核素、细胞毒性药物和免疫毒素。因而免疫导向治疗分为免疫放射疗法、免疫化学药物疗法和免疫毒素疗法。
CAS号：
性质：用有一定特异性的抗体为载体，将药物或其他杀伤肿瘤细胞的物质选择性地运送到肿瘤部位，特异地杀伤肿瘤细胞，以提高治疗效果的一种治疗方法。目前应用的细胞物质有三类，放射性核素、细胞毒性药物和免疫毒素。因而免疫导向治疗分为免疫放射疗法、免疫化学药物疗法和免疫毒素疗法。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条